Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 866 entries
View as:

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection

Phase: N/A Priority: Normal
NCT ID: NCT04913610 Org: User:
Start: 05/22/21 End: 08/29/23 Due: 08/29/24

Expanded Access to ABBV-8E12

Phase: N/A Priority: Normal
NCT ID: NCT03744546 Org: User:
Start: - End: - Due: -

Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05475821 Org: User:
Start: 07/25/22 End: 09/26/22 Due: 09/26/23

An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine

Phase: N/A Priority: Normal
NCT ID: NCT01911845 Org: User:
Start: 04/30/13 End: 09/30/14 Due: 09/30/15

The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

Phase: N/A Priority: Normal
NCT ID: NCT02618928 Org: User:
Start: 12/15/15 End: 03/29/18 Due: 03/29/19

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06701331 Org: User:
Start: 12/22/24 End: 01/31/27 Due: 01/31/28

Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece

Phase: N/A Priority: Normal
NCT ID: NCT06247319 Org: User:
Start: 04/29/24 End: 10/31/27 Due: 10/31/28

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT02899052 Org: User:
Start: 01/19/17 End: 06/22/27 Due: 06/22/28

To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)

Phase: N/A Priority: Normal
NCT ID: NCT02028169 Org: User:
Start: 01/31/14 End: 04/30/16 Due: 04/30/17

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT04895436 Org: User:
Start: 03/28/22 End: 01/31/29 Due: 01/31/30

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT04244175 Org: User:
Start: 01/27/20 End: 05/21/24 Due: 05/21/25

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02632175 Org: User:
Start: 11/26/15 End: 04/08/25 Due: 04/08/26

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02507687 Org: User:
Start: 08/27/15 End: 05/31/23 Due: 05/31/24

Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

Phase: N/A Priority: Normal
NCT ID: NCT04846959 Org: User:
Start: 07/30/21 End: 01/01/33 Due: 01/01/34

A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Phase: N/A Priority: Normal
NCT ID: NCT04274907 Org: User:
Start: 06/30/20 End: 02/02/21 Due: 02/02/22

A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05895266 Org: User:
Start: 06/23/23 End: 11/02/23 Due: 11/02/24

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04541810 Org: User:
Start: 01/26/21 End: 12/31/25 Due: 12/31/26

Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00887757 Org: User:
Start: 09/30/09 End: 11/30/11 Due: 11/30/12

Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"

Phase: N/A Priority: Normal
NCT ID: NCT02578238 Org: User:
Start: 09/24/15 End: 05/31/17 Due: 05/31/18

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02725866 Org: User:
Start: 04/05/16 End: 10/31/17 Due: 10/31/18

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02707952 Org: User:
Start: 02/22/16 End: 02/09/17 Due: 02/09/18

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Phase: N/A Priority: Normal
NCT ID: NCT06916507 Org: User:
Start: 05/06/25 End: 09/30/27 Due: 09/30/28

Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02483104 Org: User:
Start: 07/31/15 End: 07/31/16 Due: 07/31/17

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03314181 Org: User:
Start: 04/02/18 End: 08/21/25 Due: 08/21/26

A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02356562 Org: User:
Start: 02/03/15 End: 07/07/17 Due: 07/07/18